文献速递乳腺外科围术期管理与 ERAS

门诊乳房切除术:患者选择影响因素与重返医疗预测因素

Outpatient Mastectomy: Factors Influencing Patient Selection and Predictors of Return to Care.
PubMed 文献 · J Am Coll Surg · 2020-10-03

围术期静脉对乙酰氨基酚、阿片类药物和高手术量外科医生增加门诊手术几率,而双侧切除、即刻重建和ASA 3-4级降低几率。门诊患者中7%发生7天内重返医疗,ASA 3-4级和非裔美国人增加风险,静脉对乙酰氨基酚和阿片类药物处方降低风险。

要点

  • 围术期静脉对乙酰氨基酚和高手术量外科医生可提高门诊乳房切除术成功率。
  • 双侧切除、即刻重建和ASA 3-4级患者更适合住院手术。
  • 门诊患者中ASA 3-4级和非裔美国人重返医疗风险较高。

核心结论

  • 外科医生手术量和多模式镇痛药物增加门诊乳房切除术的几率。
  • 门诊手术患者中ASA 3-4级和非裔美国人重返医疗可能性更高。

研究设计与样本

  • 使用逻辑回归比较住院与门诊患者的特征、手术变量和多模式镇痛管理,并识别门诊患者重返医疗的预测因素。

主要发现

  • 2648例乳房切除术中1689例(64%)为门诊手术,患者平均年龄58.5岁。
  • 门诊手术预测因素包括围术期静脉对乙酰氨基酚(OR 1.59;95% CI,1.28至1.97)、围术期阿片类药物(OR 1.47;95% CI,1.06至2.02)和高手术量乳腺外科医生(OR 2.12;95% CI,1.42至3.18)。
  • 双侧乳房切除术(OR 0.70;95% CI,0.54至0.91)、即刻重建(OR 0.52;95% CI,0.39至0.70)和ASA 3-4级(OR 0.69;95% CI,0.54至0.87)降低门诊手术几率。
  • 门诊患者中111/1689例(7%)发生重返医疗。
  • ASA 3-4级(OR 2.01;95% CI,1.29至3.14)和非裔美国人(OR 2.30;95% CI,1.38至4.91)增加重返医疗风险,静脉对乙酰氨基酚(OR 0.56;95% CI,0.35至0.88)和填写阿片类药物处方(OR 0.51;95% CI,0.34至0.77)降低风险。

临床怎么用

  • 选择门诊乳房切除术患者时可考虑手术量大的外科医生和多模式镇痛方案。
  • 对ASA 3-4级、非裔美国人、双侧切除或即刻重建患者应加强围术期评估和随访。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: After implementation of the Surgical Home Recovery (SHR) initiative for mastectomy within a large, integrated health delivery system, most patients are discharged on the day of the procedure. We sought to identify predictors of SHR and unplanned return to care (RTC). STUDY DESIGN: Mastectomy cases with and without reconstruction from October 2017 to August 2019 were analyzed. Patient characteristics, operative variables, and multimodal pain management were compared between admitted patients and SHR patients using logistic regression. We identified predictors of RTC in SHR patients, defined as 7-day readmission, reoperation, or emergency department visit. RESULTS: Of 2,648 mastectomies, 1,689 (64%) were outpatient procedures and the mean age of patients was 58.5 years. Predictors of SHR included perioperative IV acetaminophen (odds ratio [OR] 1.59; 95% CI, 1.28 to 1.97), perioperative opiates (OR 1.47; 95% CI, 1.06 to 2.02), and operation performed by a high-volume breast surgeon (OR 2.12; 95% CI, 1.42 to 3.18). Bilateral mastectomies (OR 0.70; 95% CI, 0.54 to 0.91), immediate reconstruction (OR 0.52; 95% CI, 0.39 to 0.70), and American Society of Anesthesiologists class 3 to 4 (OR 0.69; 95% CI, 0.54 to 0.87) decreased the odds of SHR. Of SHR patients, 111 of 1,689 patients (7%) experienced RTC. Patients with American Society of Anesthesiologists class 3 to 4 (OR 2.01; 95% CI, 1.29 to 3.14) and African American race (OR 2.30; 95% CI, 1.38 to 4.91) were more likely to RTC; receiving IV acetaminophen (OR 0.56; 95% CI, 0.35 to 0.88) and filling an opiate prescription (OR 0.51; 95% CI, 0.34 to 0.77) decreased the odds of RTC. CONCLUSIONS: Surgeon volume and multimodal pain medication increased the odds of SHR. Within the SHR group, American Society of Anesthesiologists Class 3 to 4 and African American patients increased the likelihood of RTC. This study helps optimize patient selection and perioperative practice for successful SHR.

来源:J Am Coll Surg,查看原文。版权归原作者所有。

引用

  1. Vuong B, Dusendang JR, Chang SB, et al. Outpatient Mastectomy: Factors Influencing Patient Selection and Predictors of Return to Care. J Am Coll Surg. 2020. PMID: 33022403. doi:10.1016/j.jamcollsurg.2020.09.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。